No Prescription |
 |
 | ||
|
Imodium Generic Loperamide |
|
| ||
No Prescription » Prescription Drugs 9 » Imodium Generic Loperamide This medication is used to treat sudden diarrhea (including traveler's diarrhea). It works by slowing down the movement of the gut. This decreases the number of bowel movements and makes the stool less watery. Loperamide is also used to reduce the amount of discharge in patients who have undergone an ileostomy. It is also used to treat on-going diarrhea in people with inflammatory bowel disease.Loperamide treats only the symptoms not the cause of the diarrhea (e.g. infection). Treatment of other symptoms and the cause of the diarrhea should be determined by your doctor.Do not use in children younger than 6 years unless directed by your doctor. This medication should not be used in infants younger than 24 months. Buy Imodium Generic Loperamide and other Prescription Drugs 9 products online at Medstore. Buy Online at Medstore - Click Here!
About Imodium Generic Loperamide: Product Type: Prescription Drugs 9 Imodium ( Generic Loperamide ) Imodium (Generic Loperamide) Generic Loperamide 2mg 100 Tablets 2mg 400(4 x 100 Tablets) 2mg 200(2 x 100 Tablets) 2mg 400(2 x 200 Tablets) 2mg 200 Tablets Advanced 6 tabs Generic Loperamide Imodium
View more Prescription Drugs 9 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
